LOGIN  |  REGISTER
Terns Pharmaceuticals

NeueHealth (NYSE: NEUE) Stock Quote

Last Trade: US$7.29 2.98 69.14
Volume: 741,909
5-Day Change: 56.77%
YTD Change: -4.46%
Market Cap: US$60.360M

Latest News From NeueHealth

DORAL, Fla. / Dec 23, 2024 / Business Wire / NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates (“NEA”) at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become... Read More
Delivered strongest financial performance to date in Q3 ‘24, resulting from continued positive momentum in NeueCare and NeueSolutions business segments Drove positive Adjusted EBITDA for the third consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year † Well-positioned to build on success and capitalize on strategic growth opportunities in 2025 and beyond DORAL, Fla. / Nov 07, 2024 / Business... Read More
DORAL, Fla. / Oct 30, 2024 / Business Wire / NeueHealth, Inc . (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that Centrum Health, one of the Company’s value-driven clinic brands, became a wholly owned subsidiary through the Company’s acquisition of the remaining 25% equity interest of the business that it did not already own. This action simplifies NeueHealth’s corporate... Read More
DORAL, Fla. / Oct 17, 2024 / Business Wire / NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Thursday, November 7, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link . Upon registration, telephone participants will... Read More
Drove solid Q2 ‘24 results with continued focus on advancing value-driven model and delivering high-quality, consumer-centric care to all populations across the ACA Marketplace, Medicare, and Medicaid Delivered positive Adjusted EBITDA for the second consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year Positioned for continued strong performance this year and beyond, expecting to reach high end... Read More
DORAL, Fla. / Jul 18, 2024 / Business Wire / NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 7, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link . Upon registration, telephone participants will... Read More
Significantly strengthens balance sheet, positioning Company for long-term, sustainable growth Underscores the value Company delivers to payors, providers, and consumers across the industry DORAL, Fla. / Jun 24, 2024 / Business Wire / NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into a secured loan facility for up to $150 million with... Read More
DORAL, Fla. / Jun 18, 2024 / Business Wire / NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that on June 12, 2024, the Company received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company no longer satisfies the continued listing standards set forth under Section 802.01B of the NYSE’s Listed Company Manual. The... Read More
Drove strong Q1 ‘24 results, focused on delivering coordinated, consumer-centric care to all populations through strong provider and payor partnerships and proactive consumer engagement Delivered Revenue of $245.1 million, Net Income from Continuing Operations of $5.7 million, Adjusted EBITDA of $2.5 million in Q1 ‘24, laying a solid foundation for continued profitable growth in 2024 NeueCare and NeueSolutions segments... Read More
DORAL, Fla. / Apr 18, 2024 / Business Wire / NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report First Quarter financial results before the financial markets open on Wednesday, May 8, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link . Upon registration, telephone participants will receive a... Read More
DORAL, Fla. / Apr 09, 2024 / Business Wire / NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it entered into an incremental amendment to its credit facility with New Enterprise Associates (“NEA”) that increases the term loan commitment by $30 million on April 8, 2024. The proceeds of the incremental commitment are intended to be used for general... Read More
Delivered strong full year 2023 results in Continuing Business, focused on serving all populations through differentiated, value-driven care model Served 461,000 consumers, an increase of 294% from prior year on a comparable basis NeueCare and NeueSolutions segments well-positioned to drive strong performance in 2024, resulting in expected Enterprise Adjusted EBITDA between $15 million and $25 million † DORAL, Fla. / Mar 06,... Read More
DORAL, Fla. / Feb 20, 2024 / Business Wire / NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE), the value-driven healthcare company, today announced it will report Fourth Quarter financial results before the financial markets open on Wednesday, March 6, 2024, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link . Upon registration, telephone participants will... Read More
The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services MINNEAPOLIS / Jan 17, 2024 / Business Wire / Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company’s ongoing focus on its NeueHealth business, which will continue... Read More
Completes final repayment on secured credit facility eliminating the Company’s secured debt Further focuses on increasing access to value-driven healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid through its continuing business, NeueHealth Reaffirms expectation for Adjusted EBITDA profitability in 2024 MINNEAPOLIS / Jan 02, 2024 / Business Wire / Bright Health Group, Inc. (“Bright Health” or... Read More
Received all required regulatory approvals on the sale of the California Medicare Advantage business; the transaction is expected to close on or about January 1, 2024 Amended Company’s secured credit facility to reduce the final repayment resulting in approximately $30 million in savings Meaningfully improves capital position to support continuing business, NeueHealth, a value-driven consumer care delivery and provider... Read More
Q3’23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3’23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3’23 Maintaining expectation for 2023... Read More
MINNEAPOLIS / Oct 13, 2023 / Business Wire / Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link . Upon registration,... Read More
Medical claims runout is estimated to be over 98% complete and continues to track with prior forecasts Completed payments to fully satisfy risk adjustment obligations in seven states Enters into repayment agreements with CMS and four states to fully satisfy all remaining risk adjustment obligations over the next 18 months MINNEAPOLIS / Sep 19, 2023 / Business Wire / Bright Health Group, Inc. (“Bright Health” or the... Read More
Q2’23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2’23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2’23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023... Read More
Enters $60 million credit facility with NEA Announces entering permanent waiver of default on existing credit facility MINNEAPOLIS / Aug 07, 2023 / Business Wire / Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG) , the technology enabled, value-driven healthcare company, today announced that it entered into a credit facility with an investment partnership of New Enterprise Associates (“NEA”) with $60... Read More
MINNEAPOLIS / Jul 17, 2023 / Business Wire / Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Second Quarter financial results before the financial markets open on Wednesday, August 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via... Read More
Total purchase consideration of $600 million; closing is not subject to a financing condition Proceeds will be used to satisfy Bright Health’s obligations to its bank lenders, with remaining proceeds to be used towards liabilities from its discontinued ACA insurance business MINNEAPOLIS / Jun 30, 2023 / Business Wire / Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled,... Read More
Q1’23 Revenue from Continuing Business of $756.3 million, up 23% year over year on strong growth in Consumer Care external value-based consumers served Q1’23 Net Loss from Continuing Business of $94.8 million, Adjusted EBITDA Loss of $35.1 million Consumer Care segment generated positive Operating Income in Q1’23 Q1’23 California MCR was 89.0% excluding prior period Medical Costs, consistent with seasonal expectations... Read More
Cathy Smith to Step Down to Pursue New Opportunity, Effective May 12, 2023 MINNEAPOLIS / May 03, 2023 / Business Wire / Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG) , the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company’s next Chief Financial Officer, effective... Read More
Extends waiver and amendment to its credit facility through June 30, 2023 Delivers strong performance in Consumer Care Delivery business in the First Quarter, serving approximately 375,000 value-based consumers, exceeding growth expectations MINNEAPOLIS / Apr 28, 2023 / Business Wire / Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG) , today announced that it is exploring strategic alternatives for... Read More
MINNEAPOLIS / Apr 25, 2023 / Business Wire / Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report First Quarter financial results before the financial markets open on Tuesday, May 9, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via... Read More
MINNEAPOLIS / Mar 01, 2023 / Business Wire / Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial results for its fourth quarter and full year ended December 31, 2022. “The Fourth Quarter and Fiscal Year of 2022 marked a year of significant transition, as we... Read More
MINNEAPOLIS / Feb 10, 2023 / Business Wire / Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced it will report Fourth Quarter financial results before the financial markets open on Wednesday, March 1, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via... Read More
Increases 2023 Enterprise Revenue guidance to $3.4 - $3.6 billion on higher-than-expected attributed value-based consumers, greater than 30% year-over-year Revenue growth at the midpoint excluding the ACA Marketplace Insurance business Strong California Medicare Advantage enrollment during AEP; reaffirms guidance for 125K+ end of year 2023 consumers Reaffirms guidance for Adjusted EBITDA profitability in 2023 Bright Health... Read More
Bright Health Group, Inc. ("Bright Health") (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced Mike Mikan, CEO and President, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, in San Francisco, CA. Bright Health’s presentation will begin at 6:00 p.m. ET / 3:00 p.m. PT. A live... Read More
C4 Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB